Physician profile
Willie Williams
NPI 1194788729
$4,775.19
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,385 · 2020: $905 · 2021: $600 · 2022: $1,163 · 2023: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,508.64 | 2019-2023 | Rinvoq, Skyrizi |
| Amgen INC. | $546.39 | 2019-2023 | Enbrel |
| Novo Nordisk INC | $448.78 | 2019-2023 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.37 | 2019-2023 | Jardiance, Synjardy, Tradjenta |
| Janssen Biotech, INC. | $272.51 | 2021-2023 | Simponi, Stelara, Remicade |
| Astrazeneca Pharmaceuticals LP | $227.51 | 2019-2023 | Saphnelo, Farxiga |
| Pfizer INC. | $203.77 | 2019-2023 | |
| Astellas Pharma US INC | $164.99 | 2019-2020 | |
| Lilly USA, LLC | $141.87 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $133.48 | 2020-2023 | Shingrix, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $118.56 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $90.06 | 2019-2021 | |
| Almatica Pharma LLC | $85.04 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $74.23 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $64.09 | 2020-2023 | Linzess |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53.26 | 2022-2023 | Freestyle Libre 2 |
| Hikma Pharmaceuticals USA | $50.60 | 2019 | |
| Sunovion Pharmaceuticals INC. | $32.41 | 2021 | |
| Fresenius Kabi USA, LLC | $21.50 | 2023 | |
| Ani Pharmaceuticals, INC. | $19.70 | 2022 | |
| Exact Sciences Corporation | $19.04 | 2023 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $17.06 | 2022 | |
| Ucb, INC. | $16.40 | 2019 | |
| Allergan, INC. | $15.78 | 2019 | |
| Celgene Corporation | $15.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.